These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2371203)

  • 1. Asymptomatic gastric damage by drugs.
    Practitioner; 1990 Mar; 234(1484):205. PubMed ID: 2371203
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathogenic mechanism of aspirin-induced gastric ulceration and its characteristics].
    Takeuchi K; Amagase K; Abe N; Kojo A
    Nihon Rinsho; 2010 Nov; 68(11):1962-5. PubMed ID: 21061516
    [No Abstract]   [Full Text] [Related]  

  • 3. NSAID-induced gastric mucosal damage.
    Semble EL; Wu WC
    Am Fam Physician; 1987 Jun; 35(6):101-8. PubMed ID: 3332745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric mucosal injury by nonsteroidal anti-inflammatory drugs is reduced by (R)-alpha-methylhistamine and its pro-drugs in the rat.
    Morini G; Grandi D; Krause M; Schunack W
    Inflamm Res; 1997 Mar; 46 Suppl 1():S101-2. PubMed ID: 9098786
    [No Abstract]   [Full Text] [Related]  

  • 5. Images in clinical medicine. An aspirin tablet and a gastric ulcer.
    Levy DJ
    N Engl J Med; 2000 Sep; 343(12):863. PubMed ID: 10995866
    [No Abstract]   [Full Text] [Related]  

  • 6. [The epidemiology of the gastroduodenal damage induced by aspirin and other nonsteroidal anti-inflammatory drugs].
    Dobrilla G; Benvenuti S; de Guelmi A
    Recenti Prog Med; 1997 May; 88(5):202-11. PubMed ID: 9244954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warning patients about cocaine and aspirin.
    Mason EE
    Obes Surg; 1998 Jun; 8(3):312-3. PubMed ID: 9678199
    [No Abstract]   [Full Text] [Related]  

  • 8. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
    Goldstein JL; Lowry SC; Lanza FL; Schwartz HI; Dodge WE
    Aliment Pharmacol Ther; 2006 May; 23(10):1489-98. PubMed ID: 16669964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
    Yeomans ND
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled comparison of gastric lesions and gastrointestinal blood loss with fluproquazone and acetylsalicylic acid (ASA) in healthy subjects.
    Gillberg RE; Korsan-Bengtsen K; Magnusson B; Nyberg G; Schütz W
    Arzneimittelforschung; 1981; 31(5a):936-7. PubMed ID: 6973991
    [No Abstract]   [Full Text] [Related]  

  • 12. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.
    Russell RI
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S14-8. PubMed ID: 10379464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-steroidal anti-inflammatory agents in ulcerative diseases. Mucosal damage of the ventricle and duodenum].
    Manniche C; Malchow-Møller A
    Ugeskr Laeger; 1987 Aug; 149(32):2161-2. PubMed ID: 3450026
    [No Abstract]   [Full Text] [Related]  

  • 14. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
    Koch M
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [When the cardiac patient with arthritis needs aspirin and NSAID: how to protect the stomach?].
    Zeidler H
    MMW Fortschr Med; 2003 Jan; 145(5):8. PubMed ID: 12619198
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary amino-bisphosphonates: a new class of gastrotoxic drugs--comparison of alendronate and aspirin.
    Graham DY; Malaty HM; Goodgame R
    Am J Gastroenterol; 1997 Aug; 92(8):1322-5. PubMed ID: 9260798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological approach to the prevention of non-steroidal anti-inflammatory drug-induced gastropathy.
    Whittle BJ
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S43-7. PubMed ID: 10379469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranitidine effect on gastric mucosa damage in patients with rheumatoid diseases on long-term treatment with non-steroid anti-inflammatory drugs.
    Piotrowski J; Gabryelewicz A; Konturek S; Kwiecień N; Rydzewska G; Sierakowski S; Zimnoch L
    Mater Med Pol; 1986; 18(3):170-6. PubMed ID: 3807434
    [No Abstract]   [Full Text] [Related]  

  • 20. [Coxib spares the stomach. This is true also for patients with preventive aspirin administration].
    MMW Fortschr Med; 2002 May; 144(20):62. PubMed ID: 12119888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.